Elevated Plasma Levels of  -1-Anti-Chymotrypsin in Age-Related Cognitive Decline and Alzheimer's Disease: A Potential Therapeutic Target

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|26|2659-2664

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.26, 2008-09, pp. : 2659-2664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Co-agonist Site of NMDA-glutamate Receptors: A Novel Therapeutic Target for Age-related Cognitive Decline

By  

Current Pharmaceutical Design, Vol. 20, Iss. 32, 2014-10 ,pp. : 5160-5168

Bentham Science Publishers

Access to resources Recommend Favorite

Formaldehyde as a trigger for protein aggregation and potential target for mitigation of age-related, progressive cognitive impairment

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 5, 2016-02 ,pp. : 472-484

Bentham Science Publishers

Access to resources Recommend Favorite

Idebenone: a guide to its use in Alzheimer's disease, other age-related cognitive disorders and Friedreich's ataxia

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 2, 2010-02 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

The Intracellular Domain of Amyloid Precursor Protein is a Potential Therapeutic Target in Alzheimer’s Disease

By  

Current Drug Discovery Technologies, Vol. 11, Iss. 4, 2014-01 ,pp. : 243-258

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidants as a Potential Therapy Against Age-Related Neurodegenerative Diseases: Amyloid Beta Toxicity and Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 699-704

Bentham Science Publishers

Access to resources Recommend Favorite